Sagdic A, Sener O, Bulucu F, Karadurmus N, Özel H E, Yamanel L, Tasci C, Naharci I, Ocal R, Aydin A
Department of Internal Medicine, Gulhane Military Medical Academy Etlik, Ankara, Turkey.
Allergol Immunopathol (Madr). 2011 Jul-Aug;39(4):200-5. doi: 10.1016/j.aller.2010.07.006. Epub 2011 May 6.
This study was conducted to evaluate the oxidant/antioxidant balance (oxidative stress status) and plasma essential trace element levels in patients with bronchial asthma or allergic rhinitis.
A total of 94 individuals consisting of 19 allergic asthmatics; 17 non-allergic asthmatics; 22 patients with allergic rhinitis; and 36 healthy control people were enrolled into this study. Superoxide dismutase (CuZnSOD) and glutathione peroxidase (GSH-Px) activity as antioxidant defence mechanism parameters, along with malondialdehyde (MDA) as a marker of lipid peroxidation, were determined in erythrocytes of patient groups and controls. Plasma copper and zinc levels were also determined in all groups.
CuZnSOD activity was significantly lower in all groups of patients (p<0.001 for allergic asthmatics, p=0.008 for allergic rhinitis patients, and p<0.001 for non-allergic asthmatics) when compared to those of controls. Erythrocyte GSH-Px enzyme activity was not different when compared to that of the control group. Similarly, the patient groups had no difference from those of the controls with respect to erythrocyte MDA levels. While plasma Cu levels in all asthmatic patients were not different from those of the controls, allergic rhinitis patients had significantly elevated (p<0.001) Cu levels compared to those of the controls. No statistically significant difference was established between patient groups and controls with respect to plasma zinc levels.
While defective CuZnSOD activity observed in all patients groups was expected to cause an increase in lipid peroxidation indicated by high MDA levels in these patients groups, the fact that MDA levels were not different from those of controls in all patient groups indicates that other components of anti-oxidant defence system preserve their functions in these patients. On the other hand, statistically significant difference between all patients groups and controls with respect to trace elements was only observed in allergic rhinitis patients who had higher levels of Cu than those of controls.
本研究旨在评估支气管哮喘或过敏性鼻炎患者的氧化/抗氧化平衡(氧化应激状态)及血浆必需微量元素水平。
本研究共纳入94人,包括19名过敏性哮喘患者、17名非过敏性哮喘患者、22名过敏性鼻炎患者和36名健康对照者。测定患者组和对照组红细胞中超氧化物歧化酶(CuZnSOD)和谷胱甘肽过氧化物酶(GSH-Px)的活性作为抗氧化防御机制参数,同时测定丙二醛(MDA)作为脂质过氧化的标志物。所有组还测定了血浆铜和锌水平。
与对照组相比,所有患者组的CuZnSOD活性均显著降低(过敏性哮喘患者p<0.001,过敏性鼻炎患者p=0.008,非过敏性哮喘患者p<0.001)。与对照组相比,红细胞GSH-Px酶活性无差异。同样,患者组与对照组在红细胞MDA水平方面也无差异。所有哮喘患者的血浆铜水平与对照组无差异,但过敏性鼻炎患者的血浆铜水平显著高于对照组(p<0.001)。患者组与对照组在血浆锌水平方面无统计学显著差异。
虽然预计所有患者组中观察到的CuZnSOD活性缺陷会导致这些患者组中MDA水平升高所表明的脂质过氧化增加,但所有患者组的MDA水平与对照组无差异这一事实表明,抗氧化防御系统的其他成分在这些患者中保持其功能。另一方面,仅在血浆铜水平高于对照组的过敏性鼻炎患者中观察到所有患者组与对照组在微量元素方面存在统计学显著差异。